ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Corgi Beauty, Skincare & Aesthetics ETF
28.03
+0.2790
1.01%
盤後:
27.75
-0.2790
-1.00%
16:10 EDT
成交量:
32
成交額:
895
市值:
140.13萬
市盈率:
- -
高:
28.03
開:
27.75
低:
28.03
收:
27.75
52周最高:
29.89
52周最低:
24.32
股本:
5.00萬
流通股本:
5.00萬
量比:
0.00
換手率:
0.06%
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞
中信證券:維持醫美行業「強於大市」評級 頭部穩增企業勢能延續
智通财经
·
昨天
泰諾生產商和連鎖藥店敦促美國上訴法院重新審議關於該藥與自閉症存在關聯的指控所作出的裁決
路透中文
·
昨天
重發-艾伯維的經期偏頭痛治療藥物達到後期研究目標
路透中文
·
09/10
懷孕期間服用泰諾可能與女兒的子宮和卵巢變化有關
路透中文
·
09/10
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/GLAM"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GLAM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","market":"US","secType":"STK","nameCN":"Corgi Beauty, Skincare & Aesthetics ETF","latestPrice":28.0254,"timestamp":1789156800000,"preClose":27.7464,"halted":0,"volume":32,"hourTrading":{"tag":"盘后","latestPrice":27.7464,"preClose":28.0254,"latestTime":"16:10 EDT","volume":6,"amount":168.1524,"timestamp":1789157404559,"change":-0.279,"changeRate":-0.009955,"amplitude":0},"delay":0,"changeRate":0.010055358532998873,"floatShares":50000,"shares":50000,"eps":0,"marketStatus":"休市中","change":0.279,"latestTime":"09-11 16:00:00 EDT","open":27.7464,"high":28.0254,"low":28.0254,"amount":895,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"CBOE","adjPreClose":27.7464,"nav":27.74,"aum":1387000,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":27.7464,"preClose":28.0254,"latestTime":"16:10 EDT","volume":6,"amount":168.1524,"timestamp":1789157404559,"change":-0.279,"changeRate":-0.009955,"amplitude":0},"volumeRatio":0.0031186651626592056,"impliedVol":0.5022,"impliedVolPercentile":0.6625},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GLAM\",,,,,undefined,":{"symbol":"GLAM","floatShares":50000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.0031186651626592056,"shares":50000,"dividePrice":0,"high":28.0254,"amplitude":0,"preClose":27.7464,"low":28.0254,"week52Low":24.3178,"pbRate":"--","week52High":29.89,"institutionHeld":0,"latestPrice":28.0254,"eps":0,"divideRate":0,"volume":32,"delay":0,"ttmEps":0,"open":27.7464,"prevYearClose":25.82,"prevWeekClose":29.069,"prevMonthClose":28.9677,"prevQuarterClose":27.6454,"fiveDayClose":28.8959,"twentyDayClose":28.2829,"sixtyDayClose":26.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GLAM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GLAM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GLAM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GLAM\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666250692","title":"中信證券:維持醫美行業「強於大市」評級 頭部穩增企業勢能延續","url":"https://stock-news.laohu8.com/highlight/detail?id=2666250692","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666250692?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 15:55","pubTimestamp":1789199703,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中信证券发布研报称,维持医美行业“强于大市”评级。2026H1全球医美头部企业保持稳健增长,2026Q2整体增速较Q1有所减弱,成熟市场需求相对稳定,全球化渠道扩张企业成长动能更强。头部稳增企业势能延续、全球扩张企业上调指引,成熟市场竞争压力仍存。投资策略:从选取的全球医美头部上市公司样本来看,2026Q2企业经营表现延续分化,具备成熟品牌积淀、积极推进全球化及新品商业化的企业增长更优。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GLAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666757579","title":"泰諾生產商和連鎖藥店敦促美國上訴法院重新審議關於該藥與自閉症存在關聯的指控所作出的裁決","url":"https://stock-news.laohu8.com/highlight/detail?id=2666757579","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666757579?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 00:42","pubTimestamp":1789144977,"startTime":"0","endTime":"0","summary":"泰诺生产商和连锁药店敦促美国上诉法院重新审议关于该药与自闭症存在关联的指控所作出的裁决Jonathan Stempel路透9月11日-泰诺的生产商以及一群零售商和药房运营商请求联邦上诉法院重新审议其恢复了500多起有关该止痛药与自闭症所谓关联的私人诉讼的决定。原告包括据称受泰诺影响的儿童的父母和监护人。上诉法院极少重新审议其自身的裁决。目前尚无确凿的科学证据表明泰诺与自闭症或注意力缺陷多动障碍之间存在关联。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nL4S4531AJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800379.SGD","BK4585","GLAM","LU0792757196.USD","LU0889566641.SGD","IE00BFXG1179.USD","LU1267930573.SGD","RSPS","LU0128525929.USD","IE00B3T34201.USD","KVUE","BK4183","LU0708994859.HKD","LU0029864427.USD","BK4588","LU1267930813.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666599375","title":"重發-艾伯維的經期偏頭痛治療藥物達到後期研究目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2666599375","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666599375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 21:38","pubTimestamp":1789047519,"startTime":"0","endTime":"0","summary":"艾伯维表示,服用阿托格潘特的患者平均比服用安慰剂的患者少0.8天的偏头痛天数。阿托格潘特属于针对偏头痛相关信号通路的治疗药物类别。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4S45213H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689514.USD","JDOC","LU0708994859.HKD","IXJ","LU2129689431.USD","RXL","LU1934455194.USD","BK4588","TRUH","IE00BLSP4452.SGD","LU0820561909.HKD","FHLC","SG9999015978.USD","IE000WAW04H5.SGD","VHT","ABBV","LU1023059063.AUD","LU1732799900.SGD","LU0211327993.USD","LU0256863811.USD","PPH","LU2237443895.HKD","BK4559","LU0289961442.SGD","LU2089283258.USD","IE000BZT7R73.USD","LU0882574055.USD","LU2125909247.SGD","LU1236620750.USD","AGNG","LU0943347566.SGD","MEDX","LU0203345920.USD","PJP","FTXH","LU0124676726.USD","LU2237443549.SGD","LU1093756168.USD","LU2089284900.SGD","GLAM","XLV","LU1291159041.SGD","LU0057025933.USD","LU0965509010.AUD","LU1236620834.HKD","LU0069063385.USD","LU0738911758.USD","LU1934455863.HKD","IE000MB6IJN5.SGD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666534914","title":"懷孕期間服用泰諾可能與女兒的子宮和卵巢變化有關","url":"https://stock-news.laohu8.com/highlight/detail?id=2666534914","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666534914?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 00:53","pubTimestamp":1788972810,"startTime":"0","endTime":"0","summary":"在这组女童中,胎儿期接触该药物与青春期子宫较小以及青春期卵巢较小有关。菲舍尔表示,该研究无法预测任何个体女性或儿童的具体结果,并指出许多在怀孕期间使用该药物的女性所生的女儿,其卵巢测量值与未服用该药物的女性所生女儿的卵巢测量值相似。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nL4T4511L3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLAM","LU0128525929.USD","LU1267930813.SGD","LU0029864427.USD","LU1267930573.SGD","BK4183","IE00BFXG1179.USD","BK4585","IE00B3T34201.USD","LU0708994859.HKD","LU0889566641.SGD","LU0792757196.USD","RSPS","BK4588","KVUE","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":34,"pageCount":1,"totalSize":136,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GLAM\",params:#limit:6,delay:false,,,undefined,":[]}}